- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06711627
Food Provision in Prenatal Care (FPPC)
June 4, 2026 updated by: University of Arkansas
Arkansas Community Engagement Alliance: Delivering Arkansas Perinatal Outcomes for Minority and Rural Women Through Innovative System Improvement to Create Equity
The overarching research question is: "Does the provision of healthy food during pregnancy reduce the proportion of women who experience excessive gestational weight gain compared with standard of care (SoC)?"
To answer this question, the investigators will conduct a randomized controlled trial with 400 pregnant women.
Participants will be randomized 1:1 to either the Food Provision arm or the SoC arm, with approximately 200 participants per arm.
Participants randomized to the SoC arm will receive the standard clinical protocol for nutritional and gestational weight gain counseling recommended for all pregnant women, as well as $500 after delivery to be used specifically for baby items.Those randomized to the Food Provision arm will be provided the same nutritional and gestational weight gain counseling, as well as a total of $1000 during pregnancy to be used specifically for the purchase of healthy foods recommended in the nutritional counseling.
Data for the primary outcome will be collected from birth records and from surveys conducted at baseline (pre-intervention), midpoint (between 24-36 weeks gestation), and post-intervention (~8 weeks post-partum).
Study Overview
Status
Active, not recruiting
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
280
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Arkansas
-
Springdale, Arkansas, United States, 72762
- UAMS Institute for Community Health Innovation
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Aged 16-44 years
- <= 22 weeks Pregnant
- Speak English, Spanish, or Marshallese
- Valid email address
- Resides in and plans to give birth in the state of Arkansas
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Standard of Care (SoC)
The SoC arm includes implementing the standard clinical protocol for nutritional and gestational weight gain counseling recommended for all pregnant women.
Additionally, participants in the SoC arm will receive $500 after delivery to be used for baby items.
|
Standard recommended nutrition and gestational weight gain counseling.
|
|
Experimental: Food Provision
The Food Provision arm includes the same nutritional and gestational weight gain counseling provided as standard of care.
In addition, participants in the Food Provision arm will be provided with a total of $1000 during their pregnancy to be used specifically for the purchase of healthy foods.
|
Standard recommended nutrition and gestational weight gain counseling plus food provision.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Excessive Gestational Weight Gain (EGWG)
Time Frame: Baseline to Post-partum (approx. 40 weeks)
|
Pre-pregnancy weight and weight immediately prior to birth will be used to calculate total weight gain, adjusting for pre-pregnancy body mass index and weeks of gestation.
Individuals whose total weight gain exceeds established guidelines will be determined to have EGWG.
|
Baseline to Post-partum (approx. 40 weeks)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 20, 2025
Primary Completion (Estimated)
March 31, 2028
Study Completion (Estimated)
March 31, 2028
Study Registration Dates
First Submitted
November 26, 2024
First Submitted That Met QC Criteria
November 26, 2024
First Posted (Actual)
December 2, 2024
Study Record Updates
Last Update Posted (Actual)
June 8, 2026
Last Update Submitted That Met QC Criteria
June 4, 2026
Last Verified
June 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 297889
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pregnancy Complications
-
University Hospital, MontpellierInstitut National de la Santé Et de la Recherche Médicale, FranceNot yet recruiting
-
Kafrelsheikh UniversityNot yet recruitingEctopic PregnancyEgypt
-
Meir Medical CenterRecruiting
-
Northwestern UniversityTerminatedPregnancy Related | Labor ComplicationUnited States
-
Bagcilar Training and Research HospitalRecruitingEctopic PregnancyTurkey (Türkiye)
-
The George Washington University Biostatistics...Eunice Kennedy Shriver National Institute of Child Health and Human Development...Terminated
-
Oslo University HospitalRecruitingPregnancy Related | Labor Complication | Induced; BirthNorway
-
University of PennsylvaniaRecruitingEarly PregnancyUnited States
-
Medical College of WisconsinBill and Melinda Gates FoundationRecruiting
-
Washington University School of MedicineUniversity of MichiganRecruiting
Clinical Trials on Standard of Care (SoC)
-
Rhizen Pharmaceuticals SAIncozen Therapeutics Pvt LtdCompleted
-
TakedaCompletedGaucher DiseaseUnited States
-
SeaStar MedicalWithdrawnCOVID-19 | Continuous Renal Replacement Therapy | Pulmonary Edema
-
HeNan Sincere Biotech Co., LtdUnknown
-
Michelle LopezCompleted
-
Axolotl BiologixSerenaGroup, Inc.RecruitingDiabetic Foot | Foot Ulcer | Diabetic Foot Ulcer | Ulcer FootUnited States
-
Merakris TherapeuticsNot yet recruitingDiabetic Foot Ulcer
-
George Washington UniversityMedtronicCompleted
-
AtriCure, Inc.Completed
-
Summa Therapeutics, LLCNot yet recruitingPeripheral Arterial Disease Below the Knee | Peripheral Arterial Disease, Rutherford 4 and 5 with Possibility to Improve VascularizationUnited States